
Jolt Capital boosts BC Platforms with $20m
Espoo-based BC Platforms, an international healthcare data provider and software developer, in November has baged an investment of $20m from the...

Amsterdam Neogene Therapeutics aquired by AstraZeneca
Neogene Therapeutics is developing both patient-specific and shared neoantigen TCR programmes to deliver such TCRs into a patient's own T cells and...

Novadip Biosciences SA raises €40m
Belgian regenerative medicine specialist Novadip Biosciences has raised €40m to push clinical development of its two investigational adipose stem...

Henkel buys FDCA from Avantium NV
From next year, Henkel will buy FDCA to bring environmentally friendly high-performance polyurethane adhesives for electronic applications to market....

First allogeneic cancer immunotherapy hits market
On December 20th, the European Commission approved Tabelecleucel (EbvalloTM) as a monotherapy for the treatment of adult and paediatric patients who...

Novo Nordisk funds API manufacturing with €726m
Novo Nordisk’s latest expansion of R&D as well as production capacity is motivated by the need to generate more of its GLP-1 agonist semaglutide,...

Lonza collaborates with Asher Biotherapeutics Inc
Asher Biotherapeutics is a developer of targeted immunotherapies for cancer, chronic viral infections and autoimmune disorders. AB248, Asher Bio’s...